Feature | April 10, 2014

Ten-Year-Old Boy is Florida’s First Pediatric Patient to Receive S-ICD

April 10, 2014 — Cardiologists at Arnold Palmer Hospital for Children performed Florida’s first pediatric implant of a new device to prevent sudden cardiac arrest.

The device, called a subcutaneous defibrillator, protects patients from sudden cardiac arrest by providing an electrical impulse to muscles surrounding the heart. It is the world’s first device to provide protection from sudden cardiac arrest while not touching the heart or blood vessels.

Sudden cardiac arrest is a condition in which the heart suddenly and unexpectedly stops beating. If this happens, blood stops flowing to the brain and other vital organs. The condition usually causes death if not treated within minutes. [1]

Cardiologists at the hospital implanted the subcutaneous defibrillator into Jose Ramos, a 10-year-old Kissimmee, Fla., boy who went into sudden cardiac arrest in February 2014 and received cardiopulmonary resuscitation from his father to save his life.

“With the subcutaneous defibrillator, we now have a way to prevent sudden cardiac arrest in pediatric patients without having wires running through their veins and into the heart,” says Rodrigo Nehgme, electrophysiologist and cardiologist at Arnold Palmer Hospital. “It is a less invasive solution with fewer risks and will save the lives of young patients at risk for sudden cardiac arrest.”

The subcutaneous defibrillator is about the size of a deck of cards and is implanted just beneath the skin below the armpit. Cardiologists then run a wire, also beneath the skin, from the device to the front of the chest and up toward the neck. Whereas older technology monitored individual heartbeats, this new device actually analyzes heart rhythm and provides an electrical impulse when the heart goes into a dangerous rhythm.

Approximately 2,000 of the subcutaneous defibrillators have been implanted in the United States, with Ramos being only the fifth pediatric case.

References:

1. National Heart, Lung and Blood Institute (https://www.nhlbi.nih.gov/health/health-topics/topics/scda/)

For more information: www.arnoldpalmerhospital.com

 

Related Content

Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing| July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies| July 12, 2016 | Heidi Olson, Pharm.D
With the recent introduction of several novel oral...
Abbott, FIRM-guided rotor ablation, atrial fibrillation, clinical studies, Cardiostim 2016
News | EP Mapping and Imaging Systems| July 07, 2016
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits asso
AtriCure, AtriClip PRO2 LAA Exclusion System, CE Mark, left atrial appendage occlusion
News | Left Atrial Appendage (LAA) Occluders| July 05, 2016
AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA) Exclusion System...
News | Heart Failure| July 05, 2016
A research team has developed a new electric mesh device that can be wrapped around the heart to deliver electrical...
anabolic steroid abuse, ARVC, arrhythmia, stroke, British Cardiovascular Society conference
News | Cardiac Diagnostics| July 01, 2016
Research has already shown that taking anabolic steroids is associated with high blood pressure and an increased risk...
St. Jude Medical, CE Mark, SyncAV CRT, MultiPoint Pacing, CardioStim 2016
Technology | Cardiac Resynchronization Therapy Devices (CRT)| June 28, 2016
St. Jude Medical Inc. announced CE Mark approval and launch of SyncAV CRT software, designed to build upon the company’...
Allied Market Research, Congestive Heart Failure Treatment Devices Market report, ICDshea
News | Heart Failure| June 28, 2016
June 28, 2016 — A recent report published by Allied Market Research, titled, "Congestive Heart Failure (CHF) Treatmen
atrial fibrillation, stroke risk, aspirin vs blood thinners, JACC study
News | Antiplatelet and Anticoagulation Therapies| June 24, 2016
More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin...
Biotronik, CardioStim 2016 Innovation Award, MRI AutoDetect, Ilivia ICDs
News | EP Lab| June 23, 2016
Biotronik announced it was the winner of the Cardiostim Innovation Award in the category “Best Practice Improvement”...
Overlay Init